アプタマーの世界市場レポート 2025年

アプタマーの市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR25.1％で80億3,000万米ドルに成長します。予測期間の成長は、ライフサイエンスへの投資の増加、医薬品開発の拡大、がん研究の成長、緊急環境での迅速な検出、アプタマー選択技術の強化、規制当局のサポートに起因します。予測期間の主な動向には、セレックス技術の進歩、診断における用途の増加、アプタマー研究への投資、ナノテクノロジーとの技術統合、啓蒙・教育イニシアティブなどがあります。

慢性呼吸器疾患の有病率の上昇が、今後数年間のアプタマー市場の成長を牽引すると予測されています。慢性呼吸器疾患は、気道の狭窄や腫脹を特徴とし、多くの場合粘液産生の増加につながり、呼吸を複雑にし、咳、息切れ、呼気時の喘鳴などの症状をもたらします。アプタマーは、RSウイルス（RSV）の検出、疾患の早期発見、治療の補助に重要な役割を果たしています。例えば、2024年6月のオーストラリア保健福祉研究所の報告によると、2023年には慢性閉塞性肺疾患（COPD）が全疾患負担の3.6％、呼吸器疾患関連の50％を占めています。さらに、2022年にはCOPDが7,691人の死亡原因であり、これは人口10万人当たり29.6人に相当し、オーストラリアの全死亡率の4.0％を占めます。このように、慢性呼吸器疾患の有病率の増加は、アプタマー市場の成長に大きく寄与しています。

個別化医療が重視されるようになったことで、アプタマー市場は今後数年間で大きく成長すると予測されています。個別化医療とは、遺伝、ライフスタイル、環境影響などの要因を考慮し、各患者の特性に合わせた治療を行うことで、より効果的で的を絞ったヘルスケアを提供することです。この文脈において、アプタマーは、標的診断や治療のためのカスタマイズ可能な分子ツールとして機能し、個々の患者の特定の分子との正確な結合を可能にします。例えば、2022年、FDAは新たに12件の個別化医薬品を承認し、過去8年間の新薬承認の少なくとも4分の1を個別化医薬品が占めるようになりました。さらに、FDAは既存の個別化治療の適応を拡大し、新たに2件のsiRNA治療を承認し、遺伝子・細胞ベースの治療法に関するガイダンスを発表し、5件の治療法を承認しました。このように、個別化医療への関心の高まりがアプタマー市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のアプタマー市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のアプタマー市場：成長率分析
• 世界のアプタマー市場の実績：規模と成長、2019～2024年
• 世界のアプタマー市場の予測：規模と成長、2024～2029年、2034年
• 世界のアプタマー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアプタマー市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• DNAアプタマー
• XNAアプタマー
• RNAアプタマー
• 世界のアプタマー市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• SELEX
• Xアプタマー
• マラステクニック
• 世界のアプタマー市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 治療薬開発
• 研究開発
• 診断
• その他の用途
• 世界のアプタマー市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 製薬・バイオテクノロジー企業
• 学術機関および政府研究機関
• 陰極線オシロスコープ
• その他のエンドユーザー
• 世界のアプタマー市場：DNAアプタマーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 一本鎖DNA（ssDNA）アプタマー
• 二本鎖DNA（dsDNA）アプタマー
• 世界のアプタマー市場：XNAアプタマーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ペプチド核酸（PNA）アプタマー
• ロックド核酸（LNA）アプタマー
• グリシル核酸（GNA）アプタマー
• 世界のアプタマー市場：RNAアプタマーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 低分子干渉RNA（siRNA）アプタマー
• ショートヘアピンRNA（shRNA）アプタマー
• ロングノンコーディングRNA（lncRNA）アプタマー

第7章 地域別・国別分析

• 世界のアプタマー市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のアプタマー市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アプタマー市場：競合情勢
• アプタマー市場：企業プロファイル
  • Aptamer Group Limited Overview, Products and Services, Strategy and Financial Analysis
  • SomaLogic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aptamer Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aptagen LLC Overview, Products and Services, Strategy and Financial Analysis
  • NeoVentures Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Aptus Biotech
• Base Pair Biotechnologies Inc.
• AMS Biotechnology Ltd.
• Vivonics Inc.
• TriLink Biotechnologies LLC
• Noxxon Pharma SE
• AM Biotechnologies LLC
• Raptamer Discovery Group
• Kaneka Corporation
• Novaptech Inc.
• Maravai Lifesciences Inc.
• Bio-Techne Corporation
• Creative Biolabs Inc.
• IBA Lifesciences GmbH
• Aptabharat Innovations Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アプタマー市場2029年：新たな機会を提供する国
• アプタマー市場2029年：新たな機会を提供するセグメント
• アプタマー市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Aptamers are short synthetic single-stranded oligonucleotides designed to fold into specific structures and bind to target antigens, which can include proteins, molecules, peptides, cells, and tissues. They serve as molecular recognition tools for their respective targets.

There are various types of aptamers, including DNA aptamers, XNA aptamers, and RNA aptamers. DNA aptamers are specific deoxyribonucleic acid (DNA) oligonucleotides capable of binding with high affinity and specificity to target antigens such as peptides, small molecules, cells, proteins, and tissues. They find applications in the design of drug delivery systems. Technologies like SELEX (Systematic Evolution of Ligands by Exponential Enrichment), X-Aptamer, and MARAS (Mirror-Image Aptamer Reverse Selection) techniques are utilized in therapeutic development, research and development, diagnostics, and other applications. Various end users, including pharmaceutical and biotechnology companies, academic and government research institutes, and diagnostic laboratories, employ aptamers for their diverse applications.

The aptamers market research report is one of a series of new reports from The Business Research Company that provides aptamers market statistics, including aptamers industry global market size, regional shares, competitors with an aptamers market share, detailed aptamers market segments, market trends, and opportunities, and any further data you may need to thrive in the aptamers industry. This aptamers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aptamers market size has grown exponentially in recent years. It will grow from $2.65 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to need for high-specificity binders, therapeutic potential, rise in personalized medicine, potential for therapeutic areas, antibody alternatives, diagnostic point-of-care (POC) devices.

The aptamers market size is expected to see exponential growth in the next few years. It will grow to $8.03 billion in 2029 at a compound annual growth rate (CAGR) of 25.1%. The growth in the forecast period can be attributed to increasing investment in life sciences, expansion in drug development, growth in cancer research, rapid detection in emergency settings, enhanced aptamer selection techniques, regulatory support. Major trends in the forecast period include advancements in selex technology, increasing applications in diagnostics, investment in aptamer research, technological integration with nanotechnology, awareness and education initiatives.

The rising prevalence of chronic respiratory diseases is projected to drive the growth of the aptamers market in the coming years. Chronic respiratory disease is characterized by the narrowing and swelling of airways, often leading to increased mucus production, which complicates breathing and results in symptoms such as coughing, shortness of breath, and wheezing during exhalation. Aptamers play a critical role in detecting the respiratory syncytial virus (RSV), facilitating early disease identification, and aiding in treatment. For example, a report from the Australian Institute of Health and Welfare in June 2024 noted that chronic obstructive pulmonary disease (COPD) accounted for 3.6% of the total disease burden and 50% of the respiratory condition-related burden in 2023. Additionally, in 2022, COPD was the underlying cause of 7,691 deaths, equating to 29.6 per 100,000 population, and representing 4.0% of all deaths in Australia. Thus, the increasing incidence of chronic respiratory diseases is significantly contributing to the growth of the aptamers market.

The growing emphasis on personalized medicine is anticipated to significantly boost the aptamers market in the coming years. Personalized medicine involves tailoring medical treatments to the unique characteristics of each patient, taking into account factors such as genetics, lifestyle, and environmental influences to provide more effective and targeted healthcare. In this context, aptamers serve as customizable molecular tools for targeted diagnostics and therapy, enabling precise binding to specific molecules in individual patients. For example, in 2022, the FDA approved 12 new personalized medicines, which has allowed personalized medicines to account for at least a quarter of new drug approvals for each of the past eight years. Furthermore, the FDA expanded indications for existing personalized therapies, approved two new siRNA therapies, issued guidance on gene and cell-based therapies-approving five such therapies-and introduced new diagnostic indications to facilitate targeted treatment decisions for various health conditions. Consequently, the heightened focus on personalized medicine is driving the growth of the aptamers market.

Technological innovations are key trends gaining traction in the aptamers market. Leading companies in this sector are developing new technologies, such as artificial DNA aptamers, which are created using flexible and advanced methods to maintain their competitive edge. For instance, in August 2023, the FDA approved Izervay for the treatment of geographic atrophy secondary to age-related macular degeneration. Izervay presents a novel option for addressing the progression of geographic atrophy, providing hope to patients affected by this severe form of macular degeneration. This treatment aims to slow the degeneration of retinal cells associated with the condition, representing a significant advancement in vision care.

Prominent players within the aptamers market are spearheading the launch of innovative reagents like Optimer-Fc to tackle challenges prevalent in the immunohistochemistry (IHC) sector. Optimer-Fc represents a groundbreaking reagent designed specifically for automating immunohistochemistry workflows. For instance, in March 2023, UK-based biotech company Aptamer Group plc introduced Optimer-Fc, aimed at revolutionizing automated immunohistochemistry workflows, thereby effectively addressing challenges inherent in the IHC market. The company strategically collaborates with leading IHC firms, conducts meticulous validation of Optimer-Fc's performance, and orchestrates trials in partnership with top-tier pharmaceutical entities. Serving as an alternative to antibodies, Optimer-Fc seamlessly integrates Optimer binders into existing workflows, offering heightened precision and selectivity for disease biomarkers within IHC applications. This innovation assumes significance particularly amid patent expirations for IHC antibodies, presenting a patentable solution to meet evolving market needs.

In a significant development during May 2022, Epicore Biosystems, a US-based digital health and wearable solutions company, executed the acquisition of Eccrine Systems, incorporating its advanced aptamer-based sweat sensing technology into Epicore's array of wearable microfluidic solutions. The acquisition encompasses Eccrine Systems, renowned for its wearable sensor technology and electrochemical aptamer-based technology, enabling the quantification of selected biomarkers within sweat samples. This strategic move bolsters Epicore's sensor technology portfolio, enhancing its capabilities in developing wearable solutions and amplifying its proficiency in leveraging aptamer-based technologies for monitoring targeted biomarkers.

Major companies operating in the aptamers market are Aptamer Group Limited, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies Inc., AMS Biotechnology Ltd., Vivonics Inc., TriLink Biotechnologies LLC, Noxxon Pharma SE, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, Novaptech Inc., Maravai Lifesciences Inc., Bio-Techne Corporation, Creative Biolabs Inc., IBA Lifesciences GmbH, Aptabharat Innovations Pvt. Ltd., Profacgen Biotech Inc., Medi GmbH & Co. KG, Pure Biologics Sp. z o.o., Oak BioSciences Inc., Ophthotech Corporation, Novartis AG, NeoNeuro SAS, CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca PLC, GlyTech Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies Inc., IVERIC bio Inc.

North America was the largest region in the aptamers market in 2024. The regions covered in the aptamers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aptamers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aptamers market includes revenues earned by entities by providing RNA profiling and detecting cells, viruses, sugars, and antibodies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aptamers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aptamers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aptamers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aptamers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: DNA Aptamers; XNA Aptamers; RNA Aptamers
• 2) By Technology: SELEX; X Aptamer; Maras Technique
• 3) By Application: Therapeutics Development; Research and Development; Diagnostic; Other Applications
• 4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Government Research Institutes; Cathode-Ray Oscilloscope; Other End Users
• Subsegments:
• 1) By DNA Aptamers: Single-Stranded DNA (ssDNA) Aptamers; Double-Stranded DNA (dsDNA) Aptamers
• 2) By XNA Aptamers: Peptide Nucleic Acid (PNA) Aptamers; Locked Nucleic Acid (LNA) Aptamers; Glycyl Nucleic Acid (GNA) Aptamers
• 3) By RNA Aptamers: Small Interfering RNA (siRNA) Aptamers; Short Hairpin RNA (shRNA) Aptamers; Long Non-Coding RNA (lncRNA) Aptamers
• Companies Mentioned: Aptamer Group Limited; SomaLogic Inc.; Aptamer Sciences Inc.; Aptagen LLC; NeoVentures Biotechnology Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aptamers Market Characteristics

3. Aptamers Market Trends And Strategies

4. Aptamers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Aptamers Growth Analysis And Strategic Analysis Framework

• 5.1. Global Aptamers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Aptamers Market Growth Rate Analysis
• 5.4. Global Aptamers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Aptamers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Aptamers Total Addressable Market (TAM)

6. Aptamers Market Segmentation

• 6.1. Global Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Aptamers
• XNA Aptamers
• RNA Aptamers
• 6.2. Global Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• SELEX
• X Aptamer
• Maras Technique
• 6.3. Global Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics Development
• Research and Development
• Diagnostic
• Other Applications
• 6.4. Global Aptamers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical and Biotechnology Companies
• Academic and Government Research Institutes
• Cathode-Ray Oscilloscope
• Other End Users
• 6.5. Global Aptamers Market, Sub-Segmentation Of DNA Aptamers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Stranded DNA (ssDNA) Aptamers
• Double-Stranded DNA (dsDNA) Aptamers
• 6.6. Global Aptamers Market, Sub-Segmentation Of XNA Aptamers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peptide Nucleic Acid (PNA) Aptamers
• Locked Nucleic Acid (LNA) Aptamers
• Glycyl Nucleic Acid (GNA) Aptamers
• 6.7. Global Aptamers Market, Sub-Segmentation Of RNA Aptamers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Interfering RNA (siRNA) Aptamers
• Short Hairpin RNA (shRNA) Aptamers
• Long Non-Coding RNA (lncRNA) Aptamers

7. Aptamers Market Regional And Country Analysis

• 7.1. Global Aptamers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Aptamers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aptamers Market

• 8.1. Asia-Pacific Aptamers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aptamers Market

• 9.1. China Aptamers Market Overview
• 9.2. China Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aptamers Market

• 10.1. India Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aptamers Market

• 11.1. Japan Aptamers Market Overview
• 11.2. Japan Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aptamers Market

• 12.1. Australia Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aptamers Market

• 13.1. Indonesia Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aptamers Market

• 14.1. South Korea Aptamers Market Overview
• 14.2. South Korea Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aptamers Market

• 15.1. Western Europe Aptamers Market Overview
• 15.2. Western Europe Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aptamers Market

• 16.1. UK Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aptamers Market

• 17.1. Germany Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aptamers Market

• 18.1. France Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aptamers Market

• 19.1. Italy Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aptamers Market

• 20.1. Spain Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aptamers Market

• 21.1. Eastern Europe Aptamers Market Overview
• 21.2. Eastern Europe Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aptamers Market

• 22.1. Russia Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aptamers Market

• 23.1. North America Aptamers Market Overview
• 23.2. North America Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aptamers Market

• 24.1. USA Aptamers Market Overview
• 24.2. USA Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aptamers Market

• 25.1. Canada Aptamers Market Overview
• 25.2. Canada Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aptamers Market

• 26.1. South America Aptamers Market Overview
• 26.2. South America Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aptamers Market

• 27.1. Brazil Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aptamers Market

• 28.1. Middle East Aptamers Market Overview
• 28.2. Middle East Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aptamers Market

• 29.1. Africa Aptamers Market Overview
• 29.2. Africa Aptamers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Aptamers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Aptamers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aptamers Market Competitive Landscape And Company Profiles

• 30.1. Aptamers Market Competitive Landscape
• 30.2. Aptamers Market Company Profiles
  • 30.2.1. Aptamer Group Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. SomaLogic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Aptamer Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Aptagen LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. NeoVentures Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Aptamers Market Other Major And Innovative Companies

• 31.1. Aptus Biotech
• 31.2. Base Pair Biotechnologies Inc.
• 31.3. AMS Biotechnology Ltd.
• 31.4. Vivonics Inc.
• 31.5. TriLink Biotechnologies LLC
• 31.6. Noxxon Pharma SE
• 31.7. AM Biotechnologies LLC
• 31.8. Raptamer Discovery Group
• 31.9. Kaneka Corporation
• 31.10. Novaptech Inc.
• 31.11. Maravai Lifesciences Inc.
• 31.12. Bio-Techne Corporation
• 31.13. Creative Biolabs Inc.
• 31.14. IBA Lifesciences GmbH
• 31.15. Aptabharat Innovations Pvt. Ltd.

32. Global Aptamers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aptamers Market

34. Recent Developments In The Aptamers Market

35. Aptamers Market High Potential Countries, Segments and Strategies

• 35.1 Aptamers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Aptamers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Aptamers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer